Why These 5 Stocks Are on the Move on Friday

Page 5 of 5

1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is down around 5% due to the Merck news which could take some demand from monoclonal antibody therapies as a result. The Merck news could also shorten the pandemic’s length. Of the around 873 elite funds in our database, 48 were long Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) at the end of Q2.

Disclosure: None.

Page 5 of 5